Implementation of contemporary radiation therapy planning concepts for pediatric Hodgkin lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group

Practical Radiation Oncology

Volumn 5, Issue 2, 2015, Pages 85-92

  Hodgson, David C ^a,b   Dieckmann, Karin ^c   Terezakis, Stephanie ^d   Constine, Louis ^e  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BOOST RADIATION THERAPY; BREAST; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL TARGET VOLUME; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; GROSS TUMOR VOLUME; HEART; HODGKIN DISEASE; HUMAN; IMMOBILIZATION; INTERNAL TARGET VOLUME; INVOLVED FIELD RADIOTHERAPY; INVOLVED SITE RADIOTHERAPY; LUNG; ORGANS AT RISK; OVARY; PLANNING TARGET VOLUME; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SECOND CANCER; SKELETON; SOFT TISSUE; THYROID GLAND; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR VOLUME; ADOLESCENT; CHILD; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; LYMPHOMA, NON-HODGKIN; MALE; PRESCHOOL CHILD; PROCEDURES; RADIATION DOSE; STANDARDS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84924434962     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2014.05.003     Document Type: Article

References (39)

1. Meadows A.T., Friedman D.L., Neglia J.P., et al. Second neoplasms in survivors of childhood cancer: Findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009, 27:2356-2362.
2. Mulrooney D.A., Yeazel M.W., Kawashima T., et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009, 339:b4606.
3. Hodgson D.C., Hudson M.M., Constine L.S. Pediatric Hodgkin lymphoma: Maximizing efficacy and minimizing toxicity. Semin Radiat Oncol 2007, 17:230-242.
4. Schellong G. The balance between cure and late effects in childhood Hodgkin's lymphoma: The experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group. Ann Oncol 1996, 7(Suppl. 4):67-72.
5. Yahalom J., Mauch P. The involved field is back: Issues in delineating the radiation field in Hodgkin's disease. Ann Oncol 2002, 13(Suppl. 1):79-83.
6. Eich H.T., Haverkamp U., Engert A., et al. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma-a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys 2005, 63:860-865.
7. Nogova L., Reineke T., Eich H.T., et al. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: A retrospective analysis from the German Hodgkin Study Group (GHSG). Ann Oncol 2005, 16:1683-1687.
8. Fermé C., Eghbali H., Meerwaldt J.H., et al. Treatment of early stages Hodgkin disease: The EORTC-GELA H8 trials. N Engl J Med 2007, 357:1916-1927.
9. De Bruin M.L., Sparidans J., Van't Veer M.B., et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes. J Clin Oncol 2009, 27:4239-4246.
10. Hodgson D.C., Koh E.S., Tran T.H., et al. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma. Cancer 2007, 110:2576-2586.
11. Koh E.S., Tran T.H., Heydarian M., et al. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: Reduction in normal tissue dose and second cancer risk. Radiat Oncol 2007, 2:13.
12. Maraldo M.V., Brodin N.P., Aznar M.C., et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol 2013, 24:2113-2118.
13. Girinsky T., van der Maazen R., Specht L., et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines. Radiother Oncol 2006, 79:270-277.
14. Campbell B.A., Hornby C., Cunninghame J., et al. Minimising critical organ irradiation in limited stage Hodgkin lymphoma: A dosimetric study of the benefit of involved node radiotherapy. Ann Oncol 2012, 23:1259-1266.
15. Maraldo M.V., Jorgensen M., Brodin N.P., et al. The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma. Pediatr Blood Cancer 2014, 61:717-722.
16. Maraldo M.V., Aznar M.C., Vogelius I.R., Petersen P.M., Specht L. Involved node radiation therapy: An effective alternative in early-stage Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2013, 85:1057-1065.
17. Nachman J.B., Sposto R., Herzog P., et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002, 20:3765-3771.
18. Ruhl U., Albrecht M., Dieckmann K., et al. Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: An interim report at 5 years of the German GPOH-HD 95 trial. Int J Radiat Oncol Biol Phys 2001, 51:1209-1218.
19. Specht L., Yahalom J., Illidge T., et al. Modern radiation therapy for Hodgkin lymphoma: Field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 2014, 89:49-58.
20. International Commission on Radiation Units and Measurements ICRU Report 62: Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50) 1999, International Commission on Radiation Units and Measurements, Bethesda, MD.
21. Gregoire V., Mackie T.R. State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report No. 83). Cancer Radiother 2011, 15:555-559.
22. Castellino R.A., Blank N., Hoppe R.T., Cho C. Hodgkin disease: Contributions of chest CT in the initial staging evaluation. Radiology 1986, 160:603-605.
23. Jerusalem G., Warland V., Najjar F., et al. Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma. Nucl Med Commun 1999, 20:13-20.
24. Friedman L., Wolden S., Constine L., et al. AHOD0031: A phase III study of dose-intensive therapy for intermediate risk Hodgkin lymphoma: A report from the Children's Oncology Group. ASH Annual Meeting Abstracts 2010, 116:766.
25. Charpentier A.-M., Conrad T., Sykes J., et al. Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: Impact on normal tissue dose. Pract Radiat Oncol 2014, 4:174-180.
26. Shirato H., Seppenwoolde Y., Kitamura K., Onimura R., Shimizu S. Intrafractional tumor motion: Lung and liver. Semin Radiat Oncol 2004, 14:10-18.
27. Wong J.W., Sharpe M.B., Jaffray D.A., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 1999, 44:911-919.
28. Schellong G., Riepenhausen M., Bruch C., et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer 2010, 55:1145-1152.
29. Hua C., Hoth K.A., Wu S., et al. Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation. Int J Radiat Oncol Biol Phys 2010, 78:143-149.
30. Koh E.S., Sun A., Tran T.H., et al. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2006, 66:223-228.
31. Bölling T., Geisenheiser A., Pape H., et al. Hypothyroidism after head-and-neck radiotherapy in children and adolescents: Preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK). Int J Radiat Oncol Biol Phys 2011, 81:e787-e791.
32. Constine L.S., Donaldson S.S., McDougall I.R., Cox R.S., Link M.P., Kaplan H.S. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 1984, 53:878-883.
33. Shafford E.A., Kingston J.E., Healy J.C., Webb J.A., Plowman P.N., Reznek R.H. Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin's disease. Br J Cancer 1999, 80:808-814.
34. Furst C.J., Lundell M., Ahlbäck S.O., Holm L.E. Breast hypoplasia following irradiation of the female breast in infancy and early childhood. Acta Oncol 1989, 28:519-523.
35. Scheibel-Jost P., Pfeil J., Niethard F.U., Fromm B., Willich E., Kuttig H. Spinal growth after irradiation for Wilm's tumour. Int Orthop 1991, 15:387-391.
36. Mäkipernaa A., Heikkilä J.T., Merikanto J., Marttinen E., Siimes M.A. Spinal deformity induced by radiotherapy for solid tumours in childhood: A long-term follow up study. Eur J Pediatr 1993, 152:197-200.
37. Paulino A.C., Wen B.C., Brown C.K., et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys 2000, 46:1239-1246.
38. Inskip P.D., Robison L.L., Stovall M., et al. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 2009, 27:3901-3907.
39. Sigurdson A.J., Ronckers C.M., Mertens A.C., et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 2005, 365:2014-2023.